Oxford and AstraZeneca are resuming coronavirus vaccine trials after a participant fell ill
said last week that despite the halt in trials, it "is still feasible" the company's vaccine will be ready by the end of the year.
Soriot said Thursday that AstraZeneca is "on track for having a set of data that we would submit before the end of the year," Business Insider previously reported.Do you have a personal experience with the coronavirus you'd like to share? Or a tip on how your town or community is handling the pandemic? Please emailfrom Business Insider Intelligence on how COVID-19 is affecting industries.Something is loading.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Inside Akon City, the $6 billion smart city Akon is building in Africa - Business InsiderAkon, the pop star behind hits like 'Smack That,' is masterminding a $6 billion smart city in Africa backed by a shadowy investor. Inside Akon City, where everything will be funded by 'Akoin' and the singer hopes to reinvent his legacy.
Read more »
We went inside a West Bank factory to see how people make soap out of olive oil - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »
Oxford, AstraZeneca to resume coronavirus vaccine trialOxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side effect in a patient in the U.K.
Read more »
AstraZeneca coronavirus vaccine clinical trials resume in U.K. after pause over safety concerns
Read more »
WHO calls delay in AstraZeneca coronavirus vaccine trial a 'wake up call'WHO Chief Scientist Dr. Soumya Swaminathan said Thursday there's no need to be 'overly discouraged' by the news, adding that 'these things happen.'
Read more »
AstraZeneca's coronavirus vaccine hit a snag - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »